Stockscreener 앱 받기
2.83
0.35%
0.01
전일 마감가:
$2.82
열려 있는:
$2.72
하루 거래량:
39,036
Relative Volume:
0.02
시가총액:
$1.67M
수익:
-
순이익/손실:
$-5.00M
주가수익비율:
-2.4609
EPS:
-1.15
순현금흐름:
$-3.85M
1주 성능:
+4.04%
1개월 성능:
-17.49%
6개월 성능:
-25.95%
1년 성능:
-68.93%
1일 변동 폭
$2.72
$2.9392
1주일 범위
$2.62
$3.09
52주 변동 폭
$2.35
$15.54
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
명칭
Protagenic Therapeutics Inc
전화
(212) 994-8200
주소
149 FIFTH AVENUE, NEW YORK
PTIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.83 | 2.50M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Exit strategy if you’re trapped in Protagenic Therapeutics Inc.High Probability Trade Plan with Indicators - Newser
How to read the order book for Protagenic Therapeutics Inc.Free Growth Based Stock Signal Screener - Newser
Smart tools for monitoring Protagenic Therapeutics Inc.’s price actionLow Risk Trade Timing with Analysis Metrics - Newser
Sentiment analysis tools applied to Protagenic Therapeutics Inc. Equity WarrantEarnings Based Stock Performance Forecast - Newser
Why Protagenic Therapeutics Inc. Equity Warrant stock attracts strong analyst attentionFree News Based Entry Opportunity Alerts - Newser
Protagenic Therapeutics Inc. Equity Warrant stock trend forecastPre-Market Stock Movement Summary and Review - Newser
Advanced analytics toolkit walkthrough for Protagenic Therapeutics Inc. Equity WarrantMulti-Bagger Detection with Trend Tools - Newser
Volatility clustering patterns for Protagenic Therapeutics Inc. Equity WarrantCommunity Picked Stocks with Trade Insights - Newser
Earnings visualization tools for Protagenic Therapeutics Inc. Equity WarrantEquity Performance Forecast Based on AI Models - Newser
Can volume confirm reversal in Protagenic Therapeutics Inc.Safe Entry Screening with Data Backed Analysis - Newser
Ranking Protagenic Therapeutics Inc. among high performing stocks via toolsFree AI Powered High Return Stock Calls - Newser
How to escape a deep drawdown in Protagenic Therapeutics Inc. Equity WarrantBuy Opportunity Forecast for Fast Traders - Newser
Why Protagenic Therapeutics Inc. stock is on top investor watchlistsMomentum Stocks with Breakout Potential - Newser
How strong is Protagenic Therapeutics Inc. Equity Warrant company’s balance sheetDiscover stocks with superior performance - Jammu Links News
How does Protagenic Therapeutics Inc. Equity Warrant compare to its industry peersBuild a diversified portfolio for risk management - Jammu Links News
Is Protagenic Therapeutics Inc. stock overvalued or undervaluedSuperior returns - Jammu Links News
What is Protagenic Therapeutics Inc. company’s growth strategySkyrocketing investment returns - Jammu Links News
When is Protagenic Therapeutics Inc. Equity Warrant stock expected to show significant growthBuild a portfolio with strong long-term growth - Jammu Links News
How does Protagenic Therapeutics Inc. compare to its industry peersMaximize returns with data-driven strategies - Jammu Links News
Is it the right time to buy Protagenic Therapeutics Inc. Equity Warrant stockBuild a winning investment strategy - Jammu Links News
What are Protagenic Therapeutics Inc. company’s key revenue driversInvest smarter with actionable trading signals - Jammu Links News
Published on: 2025-08-03 23:37:39 - Jammu Links News
What are Protagenic Therapeutics Inc. Equity Warrant company’s key revenue driversBreakout stock performance - Jammu Links News
What makes Protagenic Therapeutics Inc. stock price move sharplyCapitalize on emerging investment opportunities - Jammu Links News
When is Protagenic Therapeutics Inc. stock expected to show significant growthUnlock daily trading alerts for profits - Jammu Links News
Why is Protagenic Therapeutics Inc. Equity Warrant stock attracting strong analyst attentionFree High-Return Strategy Alerts - Jammu Links News
What is the dividend policy of Protagenic Therapeutics Inc. Equity Warrant stockSpectacular growth rates - Jammu Links News
Is Protagenic Therapeutics Inc. Equity Warrant stock overvalued or undervaluedGet professional guidance for market timing - Jammu Links News
Is Protagenic Therapeutics Inc. Equity Warrant a growth stock or a value stockUnlock powerful investment tools for free - Jammu Links News
Does Protagenic Therapeutics Inc. stock perform well during market downturnsFree Investment Timing Strategies - Jammu Links News
What are analysts’ price targets for Protagenic Therapeutics Inc. in the next 12 monthsInvest smarter with expert stock recommendations - Jammu Links News
Is it the right time to buy Protagenic Therapeutics Inc. stockAchieve breakthrough gains with expert advice - Jammu Links News
How volatile is Protagenic Therapeutics Inc. stock compared to the marketRapidly expanding wealth - Jammu Links News
Volume spikes in Protagenic Therapeutics Inc. Equity Warrant stock – what they meanInvestment Timing Strategy with Market Filters - Newser
How to build a dashboard for Protagenic Therapeutics Inc. Equity Warrant stockTrading Volume Spike and Reversal Analysis - Newser
What makes Protagenic Therapeutics Inc. Equity Warrant stock price move sharplyEntry Confirmation Using Short-Term Forecasting - Newser
Technical signs of recovery in Protagenic Therapeutics Inc. Equity WarrantReal-Time Entry Signals for Top Stocks - Newser
Can machine learning forecast Protagenic Therapeutics Inc. recoveryImmediate Entry Point Prediction Strategy - Newser
Protagenic Therapeutics Inc. stock retracement – recovery analysisDaily Exit and Entry Price Prediction - Newser
Protagenic Therapeutics granted new patent in Japan for modified stilbenoid - TipRanks
Protagenic Therapeutics Inc (PTIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):